Trial intelligence / Profile preview

Potassium nitrate and stannous fluoride dentifrice for dentin hypersensitivity

NCT03361774Phase 2Withdrawn

Sponsor
GSK
Start
Oct 2018
Primary completion
Dec 2018
01

Overview

A Phase 2 trial of potassium nitrate in dentin hypersensitivity (DH), sponsored by GSK. Planned start Oct 2018; status: withdrawn.

02

Drugs

potassium nitrate
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT03361774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03361774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call